Gassert Chad's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Nov 14, 2025
- Accession no.
- 0001871002-25-000007
- Filed
- Nov 14, 2025
- Trade date
- Nov 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gassert ChadCIK 0001871002 | Officer (SVP - CORP. DEV. & STRATEGY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | SSaleDisposed | −14,642 | $89.07 | −$1,304,162.94 | 158,584 | Indirect | |
| Nov 13, 2025 | Common Stock | SSaleDisposed | −94 | $88.00 | −$8,272 | 158,490 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.